These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 9100818)

  • 1. Same-chemical comparison of nonanimal eye irritation test methods: Bovine corneal opacity and permeability, EpiOcular™, isolated chicken eye, ocular Irritection®, OptiSafe™, and short time exposure.
    Lebrun S; Nguyen L; Chavez S; Chan R; Le D; Nguyen M; Jester JV
    Toxicol In Vitro; 2021 Apr; 72():105070. PubMed ID: 33352259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defined approaches to classify agrochemical formulations into EPA hazard categories developed using EpiOcular
    van der Zalm AJ; Daniel AB; Raabe HA; Choksi N; Flint Silva T; Breeden-Alemi J; O'Dell L; Kleinstreuer NC; Lowit AB; Allen DG; Clippinger AJ
    Cutan Ocul Toxicol; 2024 Mar; 43(1):58-68. PubMed ID: 37905558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a defined approach for eye hazard identification of solid chemicals according to the three UN GHS categories.
    Alépée N; Adriaens E
    ALTEX; 2024; 41(3):457-468. PubMed ID: 38760936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impedance-based in vitro eye irritation testing enables the categorization of diluted chemicals.
    Weissinger H; Knetzger N; Cleve C; Lotz C
    Sci Rep; 2024 Mar; 14(1):6216. PubMed ID: 38486034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using fewer animals to identify chemical eye hazards: revised criteria necessary to maintain equivalent hazard classification.
    Haseman JK; Allen DG; Lipscomb EA; Truax JF; Stokes WS
    Regul Toxicol Pharmacol; 2011 Oct; 61(1):98-104. PubMed ID: 21745525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative methods for the replacement of eye irritation testing.
    Lotz C; Schmid FF; Rossi A; Kurdyn S; Kampik D; De Wever B; Walles H; Groeber FK
    ALTEX; 2016; 33(1):55-67. PubMed ID: 26626125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRAG working group 1. Organotypic models for the assessment/prediction of ocular irritation. Interagency Regulatory Alternatives Group.
    Chamberlain M; Gad SC; Gautheron P; Prinsen MK
    Food Chem Toxicol; 1997 Jan; 35(1):23-37. PubMed ID: 9100813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical application of non-whole animal alternatives: summary of IRAG workshop on eye irritation testing. Interagency Regulatory Alternatives Group.
    Bradlaw J; Gupta K; Green S; Hill R; Wilcox N
    Food Chem Toxicol; 1997 Jan; 35(1):175-8. PubMed ID: 9100821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRAG working group 5. Other assays. Interagency Regulatory Alternatives Group.
    Curren RD; Sina JF; Feder P; Kruszewski FH; Osborne R; Régnier JF
    Food Chem Toxicol; 1997 Jan; 35(1):127-58. PubMed ID: 9100817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eye irritation testing of nanomaterials using the EpiOcular™ eye irritation test and the bovine corneal opacity and permeability assay.
    Kolle SN; Sauer UG; Moreno MC; Teubner W; Wohlleben W; Landsiedel R
    Part Fibre Toxicol; 2016 Apr; 13():18. PubMed ID: 27083156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of ocular irritancy of prototype shampoo formulations by the isolated rabbit eye (IRE) test and bovine corneal opacity and permeability (BCOP) assay.
    Cooper KJ; Earl LK; Harbell J; Raabe H
    Toxicol In Vitro; 2001 Apr; 15(2):95-103. PubMed ID: 11287169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of eye irritation potential: statistical analysis and tier testing strategies.
    de Silva O; Cottin M; Dami N; Roguet R; Catroux P; Toufic A; Sicard C; Dossou KG; Gerner I; Schlede E; Spielmann H; Gupta KC; Hills RN
    Food Chem Toxicol; 1997 Jan; 35(1):159-64. PubMed ID: 9100818
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.